All alteration types, regardless of cancer type, resulted in lower RNA-level expression of BAP1 than unaltered samples (two-sided pairwise Mann–Whitney U test with continuity correction P< 0.01 for each alteration type; Supplementary Figure S3 and Supplementary Table S3B). This evidence concerns the gene BAP1 and cancer.